Cargando…
Gene Expression Risk Scores for COVID-19 Illness Severity
BACKGROUND: The correlates of coronavirus disease 2019 (COVID-19) illness severity following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are incompletely understood. METHODS: We assessed peripheral blood gene expression in 53 adults with confirmed SARS-CoV-2 infection...
Autores principales: | Peterson, Derick R, Baran, Andrea M, Bhattacharya, Soumyaroop, Branche, Angela R, Croft, Daniel P, Corbett, Anthony M, Walsh, Edward E, Falsey, Ann R, Mariani, Thomas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767880/ https://www.ncbi.nlm.nih.gov/pubmed/34850892 http://dx.doi.org/10.1093/infdis/jiab568 |
Ejemplares similares
-
Gene Expression Risk Scores for COVID-19 Illness Severity
por: Peterson, Derick R, et al.
Publicado: (2021) -
Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial
por: Branche, Angela R., et al.
Publicado: (2015) -
Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial
por: Branche, Angela R., et al.
Publicado: (2016) -
Transcriptomic Biomarkers to Discriminate Bacterial from Nonbacterial Infection in Adults Hospitalized with Respiratory Illness
por: Bhattacharya, Soumyaroop, et al.
Publicado: (2017) -
Bacterial Complications of Respiratory Tract Viral Illness: A Comprehensive Evaluation
por: Falsey, Ann R., et al.
Publicado: (2013)